Trial Profile
Efficacy of eculizumab in the treatment of severe antibody mediated rejection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 26 Dec 2015 New trial record